Artrya is an innovative AI-driven healthcare tech company that partners with clinics to transform cardiovascular care for patients with chest pain. They offer a rapid assessment solution for emergency and primary care settings, providing accurate stratification of chest pain patients within minutes. By integrating AI technology, Artrya enables physicians, administrators, payers, and patients to make evidence-based decisions and change the standard of care.

Their solution leverages AI-supported analysis of coronary computed tomography angiography (CCTA) to detect and evaluate arterial plaque features, offering high prognostic value. This allows for the early identification of potential heart attacks and the efficient diagnosis of at-risk patients who require further investigation and therapy. Artrya aims to change the narrative of diagnostic testing and patient admittance, moving away from a just to be sure approach to evidence-based assurance.

By avoiding unnecessary costs through overtesting and minimizing patient readmissions, Artrya helps healthcare systems save billions of dollars annually. Choose Artrya as your trusted clinical partner for precise diagnosis, personalized treatment, and preventative care. Contact them today to experience the future of cardiovascular care